Italy delays controversial registration rules
This article was originally published in RAJ Devices
Italian medical device manufacturers and distributors have been granted a four-month extension - until 30 April 2009 - to re-register their products that were already on the market when controversial and complex new registration requirements entered into force in May 20071,2. Vibha Sharma reports.
You may also be interested in...
Stay current on regulatory guidelines from around the world with Medtech Insight's Guidance Tracker. Twenty-four guidance documents have been posted on the tracker since its last update.
The risk of psychiatric disorders with chloroquine and hydroxychloroquine-containing medicines received renewed attention in the EU after they were being used as potential treatments for COVID-19.
New UK guidance explains how clinical trial sponsors and investigator sites can ensure that trial monitors securely process data in electronic health record systems that do not have a restricted access functionality.